Encision Inc (ECIA) Stock Price & Analysis
Encision Inc (ECIA) rose 0.00% to USD 0.05 as of July 25, 2026 at 22:48 UTC, according to Nexqual real-time market data.
ECIA last closed at USD 0.05; the session ranged USD 0.2–0.2 on volume of 13,357 shares. Market capitalization is $762,959, with a 52-week range of USD 0–0.4 (PNK). Source: Nexqual, July 25, 2026 at 22:48 UTC.
Key Statistics (as of July 25, 2026 at 22:48 UTC)
| Price | USD 0.05 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.05 |
| Open | USD 0.2 |
| Day Range | USD 0.2 – 0.2 |
| 52-Week Range | USD 0 – 0.4 |
| Volume | 13,357 shares |
| Market Cap | $762,959 |
| Exchange | PNK |
Technical Analysis (ECIA)
Nexqual's technical model rates ECIA "NEUTRAL" based on 4 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 22:48 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0.04) |
| MACD | 0 (positive) |
Analyst Ratings (ECIA)
Wall Street analysts rate ECIA "None", per Nexqual as of July 25, 2026 at 22:48 UTC.
| Consensus Rating | None |
|---|
Earnings (ECIA)
Source: Nexqual, July 25, 2026 at 22:48 UTC.
Financials & Fundamentals (ECIA)
| Total Revenue | $6.30M |
|---|---|
| Revenue Growth (YoY) | -2.20% |
| Gross Margin | +52.64% |
| Operating Margin | -4.15% |
| Profit Margin | -6.05% |
| ROE | -21.36% |
| Current Ratio | 2.28 |
| Free Cash Flow | $-443,747 |
Source: Nexqual, July 25, 2026 at 22:48 UTC.
Financial Health Score (ECIA)
Nexqual rates Encision Inc's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 22:48 UTC.
| Growth | Weak — Revenue -2% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — No data |
| Cash Flow | Weak — FCF negative: -$444K, burning cash |
| Efficiency | Critical — ROE -21%, ROA -5.3% |
Ownership (ECIA)
| Insider Ownership | +61.42% |
|---|---|
| Institutional Ownership | +5.48% |
| Shares Outstanding | 16.88M |
| Float | 3.52M |
Source: Nexqual, July 25, 2026 at 22:48 UTC.
Leadership (ECIA)
Encision Inc is led by Robert H. Fries (age 76), Interim President, CEO & Director, per Nexqual as of July 25, 2026 at 22:48 UTC.
| Interim President, CEO & Director | Robert H. Fries (age 76) |
|---|---|
| Vice President of Sales | Jason E. Johnson (age 50) |
From Encision Inc's Latest SEC 10-K Filing (filed 2025-07-10)
Key Strengths & Strategy (as disclosed to the SEC)
- As a result, knowledgeable clinicians are now advocating AEM technology's use.   Developing a Distribution Network is Advancing Utilization of AEM Technology   Our AEM technology, in the hands of a sales network with broad access to the surgery marketplace, will help to increase utilization and market share.
- As of March 31, 2025, we have 21 unexpired United States patents relating to specific implementations of shielding and monitoring in instruments, and we continue to add patents as we further develop our proprietary technology and its applications.   As we evolved, it was clear to us that our "active electrode monitoring" technology needed to be integrated into the standard laparoscopic instrument design.
- The facility is designed to comply with the Quality System Regulation ("QSR"), as specified in published FDA regulations.
- The most recent audit was completed in February 2023.   Patents, Patent Applications and Intellectual Proprietary Rights   We have invested heavily in an effort to protect our valuable technology, and, as a result of this effort, we have been issued 26 unexpired relevant patents that together form a significant intellectual property position.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PCYN | Procyon Corp. | USD 0.26 | ▲ 0% |
| ETCC | Environmental Tectonics Corp. | USD 1.5 | ▼ 3.85% |
| SCIA | SCI Engineered Materials, Inc. | USD 7.1 | ▲ 2.9% |
| SCND | Scientific Industries, Inc. | USD 0.58 | ▲ 0% |
| PFHO | Pacific Health Care Organizatio | USD 0.83 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 22:48 UTC. This page is informational and not investment advice.